SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer 2015

被引:28
|
作者
Aranda, E. [1 ,2 ]
Aparicio, J. [3 ]
Alonso, V. [2 ,4 ]
Garcia-Albeniz, X. [5 ,6 ]
Garcia-Alfonso, P.
Salazar, R. [7 ]
Valladares, M. [8 ]
Vera, R. [9 ]
Vieitez, J. M. [2 ,10 ]
Garcia-Carbonero, R. [2 ,11 ]
机构
[1] Univ Cordoba, Hosp Reina Sofia, Inst Maimonides Invest Biomed IMIBIC, Serv Oncol Med, Cordoba, Spain
[2] Minist Econ & Competit, RTICC, ISCiii, Madrid, Spain
[3] Hosp Univ & Politecn La Fe, Valencia, Spain
[4] Hosp Univ Miguel Servet, Zaragoza, Spain
[5] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA USA
[6] Hosp Gen Univ Gregorio Maranon, Madrid, Spain
[7] Inst Catala Oncol LHospitalet, Barcelona, Spain
[8] Complexo Hosp Univ, La Coruna, Spain
[9] Complejo Hosp Navarra, Pamplona, Spain
[10] Hosp Univ Cent Asturias, Oviedo, Spain
[11] Hosp Univ 12 Octubre, Madrid, Spain
关键词
Colorectal cancer; Metastases; Chemotherapy; Targeted agents; Surgery; Guidelines; RANDOMIZED PHASE-III; 1ST-LINE TREATMENT; OPEN-LABEL; RAS MUTATIONS; COMBINATION CHEMOTHERAPY; IRINOTECAN FOLFIRI; PLUS CAPECITABINE; PANITUMUMAB PLUS; BEVACIZUMAB; FLUOROURACIL;
D O I
10.1007/s12094-015-1434-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Colorectal cancer (CRC) is the second leading cause of cancer dead in Spain. About half the patients will eventually develop distant metastases. However, as treatment options are expanding, prognosis has steadily improved over the last decades. Management of advanced CRC should be discussed within an experienced multidisciplinary team to select the most appropriate systemic treatment (chemotherapy and targeted agents) and to integrate surgical or ablative procedures when indicated. Disease site and extent, resectability, tumor biology and gene mutations, clinical presentation, patient preferences, and comorbidities are key factors to design a customized treatment plan. The aim of these guidelines is to provide synthetic recommendations for managing advanced CRC patients.
引用
收藏
页码:972 / 981
页数:10
相关论文
共 50 条
  • [21] SEOM clinical guidelines for treatment of prostate cancer
    José Ángel Arranz Arija
    Javier Cassinello Espinosa
    Miguel Ángel Climent Durán
    Fernando Rivera Herrero
    Clinical and Translational Oncology, 2012, 14 : 520 - 527
  • [22] SEOM clinical guidelines for diagnosis and treatment of glioblastoma (2017)
    Martinez-Garcia, M.
    Alvarez-Linera, J.
    Carrato, C.
    Ley, L.
    Luque, R.
    Maldonado, X.
    Martinez-Aguillo, M.
    Navarro, L. M.
    Vaz-Salgado, M. A.
    Gil-Gil, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (01) : 22 - 28
  • [23] SEOM clinical guidelines for the diagnosis and treatment of gastric adenocarcinoma
    Rivera, Fernando
    Gravalos, Cristina
    Garcia-Carbonero, Rocio
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (07) : 528 - 535
  • [24] SEOM-GEMCAD-TTD clinical guidelines for the adjuvant treatment of colon cancer (2023)
    Pericay, Carles
    Montagut, Clara
    Reina, Juan Jose
    Melian, Marcos
    Alcaide, Julia
    Tarazona, Noelia
    Ruiz-Casado, Ana
    Gonzalez-Flores, Encarnacion
    Grana, Begona
    Gravalos, Cristina
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (11) : 2812 - 2825
  • [25] The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of colorectal cancer, 2024 update
    Wang, Feng
    Chen, Gong
    Zhang, Zhen
    Yuan, Ying
    Wang, Yi
    Gao, Yuan-Hong
    Sheng, Weiqi
    Wang, Zixian
    Li, Xinxiang
    Yuan, Xianglin
    Cai, Sanjun
    Ren, Li
    Liu, Yunpeng
    Xu, Jianmin
    Zhang, Yanqiao
    Liang, Houjie
    Wang, Xicheng
    Zhou, Aiping
    Ying, Jianming
    Li, Guichao
    Cai, Muyan
    Ji, Gang
    Li, Taiyuan
    Wang, Jingyu
    Hu, Hanguang
    Nan, Kejun
    Wang, Liuhong
    Zhang, Suzhan
    Li, Jin
    Xu, Rui-Hua
    CANCER COMMUNICATIONS, 2024, : 332 - 379
  • [26] SEOM clinical guidelines for the treatment of pancreatic cancer
    Carlos Gómez-Martín
    Manuel Hidalgo
    Josep Tabernero
    Dolores Isla
    Clinical and Translational Oncology, 2011, 13 : 528 - 535
  • [27] SEOM clinical guidelines for diagnosis and treatment of glioblastoma (2017)
    M. Martínez-Garcia
    J. Álvarez-Linera
    C. Carrato
    L. Ley
    R. Luque
    X. Maldonado
    M. Martínez-Aguillo
    L. M. Navarro
    M. A. Vaz-Salgado
    M. Gil-Gil
    Clinical and Translational Oncology, 2018, 20 : 22 - 28
  • [28] SEOM clinical guidelines for the treatment of head and neck cancer (2017)
    Iglesias Docampo, L. C.
    Arrazubi Arrula, V.
    Baste Rotllan, N.
    Carral Maseda, A.
    Cirauqui Cirauqui, B.
    Escobar, Y.
    Lambea Sorrosal, J. J.
    Pastor Borgonon, M.
    Rueda, A.
    Cruz Hernandez, J. J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (01) : 75 - 83
  • [29] SEOM clinical guidelines for the management of metastatic breast cancer 2013
    Llombart Cussac, A.
    de la Haba Rodriguez, J.
    Ruiz Simon, A.
    Alvarez Lopez, I.
    Cortes Castan, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2013, 15 (12) : 1004 - 1010
  • [30] Bevacizumab Treatment for Metastatic Colorectal Cancer in Real-World Clinical Practice
    Dinu, Ioana Mihaela
    Mihaila, Mariana
    Diculescu, Mircea Mihai
    Croitoru, Vlad Mihai
    Turcu-Stiolica, Adina
    Bogdan, Diana
    Miron, Monica Ionela
    Lungulescu, Cristian Virgil
    Alexandrescu, Sorin Tiberiu
    Dumitrascu, Traian
    Buica, Florina
    Luca, Ioana Niculina
    Lungulescu, Cristina
    Negulescu, Madalina Cristina
    Gramaticu, Iulia Magdalena
    Cazacu, Irina Mihaela
    Croitoru, Adina Emilia
    MEDICINA-LITHUANIA, 2023, 59 (02):